Jason Haas

Companies

• Odyssey Therapeutics, Inc.Chief financial officer May 7, 2026 to now¹
• LIGAND PHARMACEUTICALS INCBoard member Jun 29, 2022 to now²
• Syros Pharmaceuticals, Inc.Chief financial officer Oct 13, 2021 to Nov 20, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LPLIGAND PHARMACEUTICALS INC LGND3,981 shares⁴$1.2M at $298.50Aug 12, 2026
• OTOdyssey Therapeutics, Inc. ODTX62,908 shares⁵$1.1M at $17.57May 8, 2026
• SPSyros Pharmaceuticals, Inc.0 shares⁶Nov 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 12, 2026Sold 7,138 shares at $292.81 of LIGAND PHARMACEUTICALS INC⁴
• Aug 12, 2026Exercised options 6,138 shares at $51.56 of LIGAND PHARMACEUTICALS INC⁴
• Jun 12, 2026Sold 3,461 shares at $256.08 of LIGAND PHARMACEUTICALS INC⁷
• Jun 12, 2026Sold 3,000 shares at $255.01 of LIGAND PHARMACEUTICALS INC⁷
• Jun 12, 2026Exercised options 1,000 shares at $51.56 of LIGAND PHARMACEUTICALS INC⁷
• Jun 12, 2026Exercised options 3,000 shares at $51.56 of LIGAND PHARMACEUTICALS INC⁷
• Jun 5, 2026Granted 836 shares of LIGAND PHARMACEUTICALS INC⁸
• May 8, 2026Bought 1,000 shares at $20.00 of Odyssey Therapeutics, Inc.⁵
• Jun 6, 2025Granted 1,209 shares of LIGAND PHARMACEUTICALS INC⁹
• Nov 18, 2024Sold 137,803 shares at $0.21 of Syros Pharmaceuticals, Inc.⁶
• Oct 31, 2024Shares withheld for tax 5,624 shares at $2.09 of Syros Pharmaceuticals, Inc.¹⁰
• Oct 31, 2024Exercised options 18,875 shares of Syros Pharmaceuticals, Inc.¹⁰
• Sep 12, 2024Bought 45,344 shares at $1.68 of Syros Pharmaceuticals, Inc.¹¹
• Sep 11, 2024Bought 19,293 shares at $1.58 of Syros Pharmaceuticals, Inc.¹¹
• Sep 10, 2024Bought 35,363 shares at $1.55 of Syros Pharmaceuticals, Inc.¹¹
• Jun 14, 2024Granted 1,252 shares of LIGAND PHARMACEUTICALS INC¹²
• Apr 1, 2024Shares withheld for tax 4,732 shares at $5.12 of Syros Pharmaceuticals, Inc.¹³
• Mar 31, 2024Exercised options 13,333 shares of Syros Pharmaceuticals, Inc.¹³
• Mar 31, 2024Exercised options 2,000 shares of Syros Pharmaceuticals, Inc.¹³
• Nov 1, 2023Shares withheld for tax 6,301 shares at $2.22 of Syros Pharmaceuticals, Inc.¹⁴
• Oct 31, 2023Exercised options 18,875 shares of Syros Pharmaceuticals, Inc.¹⁴
• Jun 9, 2023Granted 1,142 shares of LIGAND PHARMACEUTICALS INC¹⁵
• Apr 3, 2023Shares withheld for tax 623 shares at $2.58 of Syros Pharmaceuticals, Inc.¹⁶
• Mar 31, 2023Exercised options 2,000 shares of Syros Pharmaceuticals, Inc.¹⁶
• Jun 29, 2022Granted 1,750 shares of LIGAND PHARMACEUTICALS INC¹⁷